GenEros Biopharma Ltd. was registered at Cayman Islands in 2015 and foundered at Hangzhou, China in 2018. The company was foundered based on Dr. Fu’s original discoveries of the JAK-STAT cell signaling pathways and the Th-GM T cell subpopulation, as well as their important regulatory functions in various human diseases. The company is scientific discovery-driven drug development company focusing on developing first-in-class drugs in treating inflammation, autoimmune diseases, and cancer.
Winner of the highest potential award of Qiantang new district.
Winner of the 2019 “Small and Beautiful” company award of Hangzhou.
Opening of the Chemistry department in Shanghai.
Opening ceremony at Xiasha district.
Winner of the top talent award of Hangzhou Economic Development Zone.
GenEros Biopharma Ltd. was registered.
Copy Right © 2020 GenEros BioPharma Ltd.. All rights reserved. 浙ICP备2021009480号 SiteMap